🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A CRISPR screen targeting RNA identifies essential lncRNAs in human cells, revealing lncRNAs whose expression correlates with the survival of tumors, identifying new biomarkers and potential targets for therapeutics cell.com/cell/fulltext/… #NBThighlight

Big thanks to Neville for the insightful tutorial on our work! Grateful for the guidance and support every step of the way.

Thanks for covering our work!

Excited to share our recent Cell publication in #cshldata24 #biodata24! Drop by #123 at Busch to know more about identification of essential lncRNAs using new kind of CRISPR screen!

I’m excited to share our latest study in @nature on this novel compound called Gliocidin, that targets glioblastoma (#GBM), the most malignant brain tumor. #drugdiscovery #cancer #cancermetabolism GSK Graduate School Memorial Sloan Kettering Cancer Center nature.com/articles/s4158…

Every time I hear about this story, I’m amazed by how their CRISPR-Cas9 screen uncovers the missing jigsaw piece in the mechanism of this glioblastoma drug—and by my friend and fellow climber Yu-Jung Chen brilliance in connecting the dots. Now it’s finally out in nature!

NIH's new policy (NOT-OD-25-068) capping indirect cost reimbursement at 15% threatens the future of research, training, & scientific infrastructure at research institutions nationwide. The NYGC has drafted a petition urging reversal. Please sign & share: bit.ly/40KK21a